Narrow Results

Electroacupuncture (EA) has been shown to induce potent analgesic effects on neuropathic pain in both patients and rodents. Cell therapy to release antinociceptive agents near the pain processing centers of the spinal cord is a promising next step in the development of treatment modalities. This study investigated the effects of the combination of EA and cell therapy by glial cell line-derived neurotrophic factor (GDNF) on neuropathic pain in rats. The hyperalgesic state was induced by chronic constriction injury (CCI) of the sciatic nerve and fibroblasts genetically modified to secrete bioactive GDNF (FBs-GDNF) were used for cell therapy. Fifty-eight rats with neuropathic pain were randomly divided into five groups (CCI+PBS, n = 11; CCI+FBs-GDNF, n = 12; CCI+EA+PBS, n = 11; CCI+EA+FBs-pLNCX2, n = 12; CCI+EA+FBs-GDNF, n = 12). On the 7th day after CCI, the rats received intrathecal transplantation of FBs-GDNF or control fibroblasts (FBs-pLNCX2). In the meantime, EA was administered once every other day from the 7th day after CCI surgery for 21 days. The paw withdrawal latency (PWL) to radiant heat was measured every other day. The results showed that the ipsilateral PWL of the rats from all three EA treatment groups significantly increased starting on the 12th day compared with the PBS control group. Strikingly, the group which received EA treatment and FBs-GDNF transplantation (CCI+EA+FBs-GDNF) showed a significantly decreased thermal hyperalgesia after 2 weeks post CCI surgery compared with the groups which received EA treatment and FBs-pLNCX2 transplantation (CCI+EA+FBs-pLNCX2) or PBS (CCI+EA+PBS) as well as the FBs-GDNF transplantation group without EA treatment (CCI+FBs-GDNF). Our data suggest that EA and cell therapy can synergistically attenuate hyperalgesia in neuropathic pain rats.

The degeneration of intervertebral discs is one of the pathophysiological causes of lowback pain which has been seriously disturbing human health at the present, No clinical approach can provide prophylaxis or treatment for disc degeneration. But people are now thinking about gene transfer for the prevention of disc degeneration to reduce the incidence of back pain. This idea originated from the development of molecular biology; the deep understanding of the physiology and biochemistry of the intervertebral discs, and the growing scope of gene therapy. The increasing publications on gene therapy for disc degeneration have shown us the future of this research field, and revealed possible difficulties in the process of the study. This article focuses on several important aspects of gene therapy for disc degeneration.

"Brain Hole" Finding Brings New Insight to Parkinson's Disease.

Gene Therapy for Prostate Cancer.

Robotic Pediatric Cardiac Surgeries Successful in China.

Chinese Scientists Found New Gene Remedy for Cancer.

Genetically Engineered Potato on the Way.

Device Offers Bloodless Checks for Diabetics.

Researchers Draws Stem Cells from Mouse Pancreases.

Top NZ Scientist Works on Designer Trees.

Gene Research at Canterbury University Earns International Praise.

No Conclusive Evidence that Organic Produce is More Nutritious.

Singapore to Use Mosquito as Weapon against Dengue.

Scientist Warns of New Eye Correction Treatment.

Pre-Germinated Brown Rice May Possibly Benefit Alzheimer’s Patients.

Genetically Engineered Plants for Preventing Diabetes.

Gene Therapy — A Novel Treatment for Alzheimer’s.

Potential New Treatment for Stroke and Neurodegenerative Diseases.

Latest Developments in Gene Therapy.

The Status and Promise of Cancer Gene Therapy.

Beauty and Beast: The Promises and Concerns of Gene Therapy Vectors.

How Safe is Gene Therapy?

Gene Therapy of Cancer.

Private Stem Cells Initiatives.

Placenta-derived Multipotent Cells.

Somatic Cell Nuclear Transfer.

Diabetes Research Sweetened by Stem Cell License.

Xeno-free Stem Cell Research.

Asia’s Emerging Eminence in Stem Cell Field.

UK Determined to Maintain Lead – Call for Stem Cell Fund.

Chinese Scientists Achieve Stem Cell Breakthrough.

Stem Cell Lines in Disarray: Shakeup for Global Research.

The Promise of Gene Therapy.

Forthcoming: A Vaccine for Cervical Cancer.

A Safer and More Effective "Aspirin".

Scientists Uncover A New Method of Producing NK Cells.

Insight into the Human Genome Through the Elephant Shark.

Using Gene Therapy for Alzheimer's Disease.

Drug Delivery in Cancer Therapy.

Transdermal Drug Delivery.

Nanotechnology and Drug Delivery.

Types of Drug Delivery Systems.

Artificial Cells Containing Stem Cells for Liver Failure.

Stem Cells and Regenerative Medicine.

Towards a Universal Platform for Autologous Stem Cell Gene Therapy: the Induced Pluripotent Stem Cell Breakthrough.

CHINA – Cambrian "Walking Cactus" Found in China.

HONG KONG – HKU Identifies Early Target Cells of SARS.

TAIWAN – Silk Transistor Discovery.

THAILAND – Dengue Vaccine Breakthrough in Land of Smiles.

EUROPE – End to Yearly Flu Vaccines?

USA – Artificial Retina Breakthrough.

USA – Chemist Shortcuts Drug Processing.

USA – Exciting Potential in New HIV Gene Therapy.

USA – Gems Augment Chemotherapy.

USA – World's First Tissue-Engineered Urethras a Success.

USA – Cancer Drug May Save Preemies' Sight.

USA – Proteins Now for Biofuels, Biorefining.

OTHER REGIONS — Banana Peels Purify Water.

EUROPE – Biomarkers for Autism Discovered.

EUROPE – New Research Could Stop Tumor Cells From Spreading.

EUROPE – Dutch Scientists Deliver Drugs with Nanorockets.

EUROPE – "Living" Micro-Robot Could Detect Diseases in Future.

EUROPE – Animal Import Bans Threaten UK Drug Research.

EUROPE – £100M Welsh Biotech Fund Inspired by Sir Chris Evans.

EUROPE – Scientists Discover New Plasmodium Mechanism.

INDIA – Landmark Gleevec IP Case Makes Big Pharma Think Twice.

INDIA – Indian Govt Defends Generics Industry.

JAPAN – Japan May Open $96 Billion Drug Market Further.

SINGAPORE – Temasek Foundation and Temasek Life Sciences Laboratory Collaborate in Myanmar.

SINGAPORE – NCIS, NCCS and ESMO to Launch Cancer Education Initiative.

TAIWAN – Taiwan Lags Behind South Korea in Biotech.

TAIWAN – NCHU Inaugurates Taiwan-U.S. Research Center on Plant and Food Biotech.

TAIWAN – Taiwan Offers New Model to Predict Hepatitis C Cancer Risk.

TAIWAN – Nobel Laureate Dr. Ada E. Yonath to Lecture in Taipei.

USA – BIO Opens Nominations for 2012 Biotech Humanitarian Award.

USA – Pharmaceuticals Survey: Many Think Business Model Is Broken.

USA – Probe Proteins Ultrafast with Infrared Spectroscopy.

USA – This DNA Cannot be Replicated.

USA – New Single-Cell, Single-Molecule Method to Identify DNA.

USA – New Gene Therapy Approach Could Treat Sickle Cell.

USA – Clamor Affects More than Birds and Other Animals.

USA – The End of RNA World?

USA – Curly Leaves Inspire New Technique for Shaping Thin Gel Sheets.

USA – Mutant Plants May be Better for Biofuels.

USA – Breakthrough in ID'ing Target Cancer Epigenetic Genes.

AUSTRALIA – Origins of plague: Scientists reveal the cause of one of the most devastating pandemics in human history.

AUSTRALIA – Admedus releases interim phase I results for Herpes study.

CAMBODIA – Study tags cause of malaria drug resistance in Cambodia.

JAPAN – Discovery of mechanism by which sex hormone regulates aggressive behavior.

SINGAPORE – Singapore's first influenza vaccines demonstrates favorable immunogenicity and tolerability in clinical testing.

SINGAPORE – Scientists from Genome Institute of Singapore and Stanford University show RNA architecture expanding understanding of human genetics.

SINGAPORE – “Bio-Timer” that synchronizes growth.

SINGAPORE – Researchers make new discovery of protein as a promising target for treatment of anaplastic thyroid carcinoma.

AFRICA – African project aims to stop rats in their tracks.

AFRICA – African monsoon project to benefit crops and healthcare.

CANADA – Cancer researchers discover pre-leukemic stem cell at root of AML relapse.

EUROPE – Understanding heart failure at the cellular level.

INDIA – Africa and India cultivate agricultural research ties.

UNITED STATES – Three major genes set feather hue in pigeons.

UNITED STATES – Mouse study shows gene therapy may be possible cure for Hurler syndrome.

UNITED STATES – The ultimate decoy: Scientists find protein that helps bacteria misdirect immune system.

Asia's Medical Technology Start-ups Get New Fast Track to Market via Partnership between Cambridge Consultants and Clearbridge Accelerator

Mitsubishi Electric and Sembcorp Industries to Testbed Novel Ozone Backwashing Energy-Saving Membrane Bioreactor

LEO Pharma Enters Biologics through Strategic Partnership with AstraZeneca

Bayer and X-Chem Expand Drug Discovery Collaboration to Discover Novel Medicines

New Gas Chromatography System Brings Power of Orbitrap GC-MS Technology to Routine Applications

A*STAR and MSD Establish a New Research Collaboration to Advance Peptide Therapeutics

Stem Cells Engineered to Grow Cartilage, Fight Inflammation

Drug development companies in APAC need to raise their game to capitalise on the $33bn+ immuno-oncology treatment opportunity

Singapore’s pharmaceutical market value to reach $1.15 billion by 2021

Ryzodeg reduces hypoglycaemia in type 2 diabetic fasting patients

FDA approves Amgen’s Repatha (evolocumab) to prevent heart attack and stroke

FDA approves first drug for rare disease, eosinophilic granulomatosis with polyangiitis

FDA approves first biosimilar for the treatment of certain breast and stomach cancers

FDA approves novel gene therapy to treat patients with a rare form of inherited vision loss

Singapore institutes collaborate with Samsung Medical Center to improve treatment of liver cancer

Globavir announces partnership with Singhealth Duke-NUS Academic Medical Centre to study dengue treatment

Mundipharma secures exclusive license for the development and commercialisation of PAION’s remimazolam in Japan

£30 million global cardiovascular disease challenge open for applications.

World’s first gene therapy for osteoarthritis to be available in Asia-Pacific.

FDA approves six-in-one vaccine for children.

Lucence Diagnostics opens new headquarters in Singapore.

Accuron Technologies spins out medtech business.

CRISPR gene-editing not as precise as thought, warns of safety risks

Insomnia spreads among young Chinese

African swine fever virus isolated in Northeast China

China launches new stem cell clinic programs

Protein in human body could inhibit progress of HIV

Chinese HEV vaccine begin clinical trial in U.S.

New screening method for early diagnosis of liver cancer in hepatitis B carriers

Merck collaborates with GenScript to accelerate cell and gene therapy industrialisation in China

Shineco expands to capture industrial cannabis market

Research from XJTLU advances RNA modification mapping

Advances in medical research have shed light on the genetic cause of many human diseases. Gene therapy is a promising approach which can be used to deliver therapeutic genes to treat genetic diseases at its most fundamental level. In general, nonviral vectors are preferred due to reduced risk of immune response, but they are also commonly associated with low transfection efficiency and high cytotoxicity. In contrast to viral vectors, nonviral vectors do not have a natural mechanism to overcome extra- and intracellular barriers when delivering the therapeutic gene into cell. Hence, its design has been increasingly complex to meet challenges faced in targeting of, penetration of and expression in a specific host cell in achieving more satisfactory transfection efficiency. Flexibility in design of the vector is desirable, to enable a careful and controlled manipulation of its properties and functions. This can be met by the use of bolaamphiphile, a special class of lipid. Unlike conventional lipids, bolaamphiphiles can form asymmetric complexes with the therapeutic gene. The advantage of having an asymmetric complex lies in the different purposes served by the interior and exterior of the complex. More effective gene encapsulation within the interior of the complex can be achieved without triggering greater aggregation of serum proteins with the exterior, potentially overcoming one of the great hurdles faced by conventional single-head cationic lipids. In this review, we will look into the physiochemical considerations as well as the biological aspects of a bolaamphiphile-based gene delivery system.

In applications such as gene therapy and drug design, a key goal is to convert the disease state of diseased objects from an undesirable state into a desirable one. Such conversions may be achieved by changing the values of some attributes of the objects. For example, in gene therapy one may convert cancerous cells to normal ones by changing some genes' expression level from low to high or from high to low. In this paper, we define the disease state conversion problem as the discovery of disease state converters; a disease state converter is a small set of attribute value changes that may change an object's disease state from undesirable into desirable. We consider two variants of this problem: personalized disease state converter mining mines disease state converters for a given individual patient with a given disease, and universal disease state converter mining mines disease state converters for all samples with a given disease. We propose a DSCMiner algorithm to discover small and highly effective disease state converters. Since real-life medical experiments on living diseased instances are expensive and time consuming, we use classifiers trained from the datasets of given diseases to evaluate the quality of discovered converter sets. The effectiveness of a disease state converter is measured by the percentage of objects that are successfully converted from undesirable state into desirable state as deemed by state-of-the-art classifiers. We use experiments to evaluate the effectiveness of our algorithm and to show its effectiveness. We also discuss possible research directions for extensions and improvements. We note that the disease state conversion problem also has applications in customer retention, criminal rehabilitation, and company turn-around, where the goal is to convert class membership of objects whose class is an undesirable class.